Articles Archives - Page 432 of 787

ThursdayAug 19, 2021 12:07 pm

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) and Bloombox UK Subsidiary, Partner with Disney in the UK to Promote Release of Jungle Cruise Film

PlantX recently announced that its wholly owned UK-based subsidiary, Bloombox, has partnered with Disney in a co-branded campaign The campaign, aimed at promoting Bloombox products and celebrating the release of Disney's new adventure-filled film, Jungle Cruise, will feature the launch of exotic plants, a treasure hunt, and a social media campaign According to PlantX CEO Lorne Rapkin, the collaboration legitimizes the company's presence in the plant-based space, supporting the fact that it is indeed a true player in the space The company considers the partnership an opportunity to celebrate plants and their integral role and impact across the film industry…

ThursdayAug 19, 2021 11:52 am

Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) Is ‘One to Watch’

Delic is led by a best-in-class team of industry veterans with over 100 years of working knowledge in cannabis, finance, and psychedelic research The Vancouver-based company was formed in 2019 as the ‎first psychedelic umbrella platform The Delic self-sustaining Ecosystem covers three main areas: media, health, and science On March 4, 2021, Delic announced its acquisition of Seattle-based Homestead Book Company, a legacy counterculture distributor of psychedelic media An estimated $238 billion is spent annually in the U.S. on mental health treatments and ancillary services University-led and FDA-approved studies are positioning North America as a leading region in the advancement…

ThursdayAug 19, 2021 11:40 am

ISW Holdings Inc. (ISWH) Finalizes Major Hosting/Mining Agreement with Global Leader Bitmain to Launch New Cryptocurrency Mining Operation

The two crypto space leaders have signed an agreement that will form backbone of ISWH’s phase-one launch of cryptocurrency hosting, mining operation in Georgia “Bitmain is probably the most recognizable name in the mining space,” said ISWH CEO China’s recent crackdown on cryptomining creates added opportunity, making ISWH-Bitmain partnership even more promising ISW Holdings (OTC: ISWH), a global brand management holdings company with commercial operations in renewable energy cryptocurrency mining, is teaming up with Bitmain Technologies, the world’s leading producer of cryptocurrency mining hardware and a leading global cryptocurrency mining firm (https://ibn.fm/pjea0). The two crypto space leaders have signed a…

ThursdayAug 19, 2021 11:14 am

Cybin Inc. (NEO: CYBN) (NYSE American CYBN) Adelia Acquisition Making Impact, Reaching Milestones

Cybin subsidiary achieved certain milestones as outlined in acquisition agreement Adelia brought numerous advantages to company Acquisition may advance “Cybin’s ability to innovate our psychedelic drug development program and diversify beyond major depressive disorder,” says CEO Cybin's (NEO: CYBN) (NYSE American CYBN) most recent acquisition, Adelia Therapeutics Inc., is already reporting success for the company (https://ibn.fm/ZtWL2). Cybin recently announced that the wholly controlled subsidiary had achieved certain milestones for the year as outlined in the acquisition agreement, resulting in Adelia shareholders receiving common shares in Cybin. Cybin closed on the acquisition of Adelia late last year, with the company noting…

ThursdayAug 19, 2021 10:35 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Partners with Calvert Labs, Gad Consulting Services to Conduct Preclinical Bridging Studies in Preparation for Phase 2b Clinical Trials

Tryp Therapeutics recently announced new agreements with Calvert Labs and Gad Consulting Services, the second in a series of upcoming bridging studies aimed at facilitating the advancement of TRP-8803 into Phase 2b clinical trials Calvert Labs will design and execute the exploratory studies, while Gad Consulting Services will advise on certain aspects of the studies Calvert Labs shall perform TRP-8803 and TRP-8802 are psilocybin-based products being evaluated under Tryp’s PFN program Tryp intends to use TRP-8802 in the Phase 2a clinical trials, while TRP-8803 will be used in Phase 2b clinical trials and beyond The San Diego-based pharmaceutical company, Tryp…

ThursdayAug 19, 2021 10:01 am

Brain Scientific Inc. (BRSF) Addresses Growing Epilepsy Problem With Portable Low-Cost Brain Monitoring Devices

CDC reports epilepsy is growing problem, 3.4 million people afflicted in the US According to report, adult cases rose from 2.3 million to 3 million between 2010 and 2015, pediatric cases increased 450,000 to 470,000 over same period Brain Scientific produces patented devices that can be used to provide instant EEG tests to millions of US hospital patients each year More Americans are suffering from epilepsy than ever before, according to a report by the Center for Disease Control (“CDC”) that states that at least 3.4 million people live with the disorder in the United States (https://ibn.fm/PmF2b). Brain Scientific (OTCQB:…

ThursdayAug 19, 2021 9:20 am

Friendable Inc.’s (FDBL) Fan Pass App and Video Trailer Roll-outs Herald New Era of Music for the Masses

Entertainment technology innovator Friendable is pioneering a platform that boosts artists’ ability to brand and market themselves as well as fans’ ability to discover, follow and interact with artists Friendable’s Fan Pass platform has been approved by both the Apple App and Google Play stores, making it available now for download to mobile devices Friendable has signed thousands of Fan Pass artists to its platform during the past year, and is open to musicians at all levels of professional development As the company moves to shore up its revenue projections, it is also preparing to develop a series of NFTs…

WednesdayAug 18, 2021 10:00 am

Microdose Psychedelic Insight’s Psychedelic Capital: August 2021 to Highlight the Latest Developments and Breakthroughs in the Global Psychedelic Medicine Industry

Microdose Psychedelic Insights will host the upcoming Psychedelic Capital: August 2021 conference on August 31, 2021 Part of a dedicated investor conference series, the conference will host presentations from companies within the functional mushrooms, and psychedelic-based medical therapies sectors Microdose Psychedelic Insights (“Microdose”) will host their virtual Psychedelic Capital: August 2021 conference on August 31, 2021. The event will play host to a number of companies from across the psychedelics industry, including, but not limited to, the functional mushrooms and phytopharmaceutical sectors. Microdose Psychedelic Insights, a cutting-edge media company focused on creating content, financial analysis, and engaging events in the…

WednesdayAug 18, 2021 9:30 am

American Cannabis Partners Produces Top-Grade Organic Cannabis While Emphasizing Social Responsibility and Sustainable Growing Practices

American Cannabis Partners provides organic medical-grade and recreational cannabis through sustainable and environmentally friendly growing practices 80% of production output supplies manufacturing, distribution, and retail licenses, 20% is distributed to select California distributors or will be sold under ZÜK brand at company retail location in Michigan Company leverages Link4 Corporation’s cloud-powered software and environmental control technology to develop specialized strains, maximize yields, reduce operating costs American Cannabis Partners (“ACP”), a privately-owned large-scale organic cannabis cultivation company, is committed to business operations that provide top-quality medical-grade and recreational cannabis while positively impacting the environment with sustainable growing practices. American Cannabis Partners…

WednesdayAug 18, 2021 9:30 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Patented Technology Increasing Effectiveness and Potentially Lowering Healthcare Costs

Company’s patented DehydraTECH(TM) technology is showing the potential of reducing healthcare costs by improving oral medication administration – using capsule and pill form over injection administration Lexaria’s offering could potentially offer accelerated regulatory filing with the FDA and other regulators around the world The company sub-licenses its DehydraTECH technology for the delivery of fat-soluble active molecules and drugs while also operating four subsidiary companies Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, recently announced results from an anti-viral drug molecular characterization study performed by the National Research Council (“NRC”). Results confirmed that the drugs tested remained stable and…

Site Search

Company Search

Category: Articles